AYYAN’s rights trading period ends today

Logo of AYYAN Investment Co.

AYYAN Investment Co.’s rights trading period to raise the company’s capital to SAR 1 billion from SAR 806.36 million closes today, July 21. The rights trading process started on July 14.

Meanwhile, subscription to new shares will end on July 24.

For More IPOs

Rights holders can wholly or partially subscribe to the new shares up to the number of rights available in their portfolios.

Capital Increase Details
Current Capital	SAR 806.36 mln
Number of Shares	80.64 mln
New Capital	SAR 1.006 bln
Number of Shares	100.64 mln
Percentage of Capital Increase	24.80%

Rights Issue Details
Offered Shares	20 mln
Offer Price	SAR 10
Issue Size	SAR 200 mln
Eligibility Ratio	Each shareholder is entitled to subscribe to 0.2480 rights per every share held
Record date	July 8 (Shareholders of record who are registered with Edaa by the end of the second trading day following the EGM)
Trading period	July 14-21, 2024
Subscription period	July 14-24, 2024
Offering Proceeds (SAR mln)	Purchase of medical devices and equipment for Al-Salam Hospital, affiliated with Al-Salam Medical Services Co. (a subsidiary)	20.0
	Payment to suppliers of subsidiary companies (Al Ahsa Medical Services and Al-Salam Medical Services)	61.1
	Payment of outstanding obligations to financial entities by its subsidiary Al-Salam Medical Services	45
	Payment of operational expenses for its subsidiary Al-Salam Medical Services	67.9
	Offering costs	6.0
	Total	200
Financial advisor, lead manager and underwriter	Alinma Investment

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Most Read

Market Indices

Quotes

Popular Links

Quick Links

About Us

Join Us

Follow Us